Header Logo

Connection

Doris Benbrook to Aza Compounds

This is a "connection" page, showing publications Doris Benbrook has written about Aza Compounds.
Connection Strength

0.695
  1. Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53. Int J Cancer. 2020 08 15; 147(4):1086-1097.
    View in: PubMed
    Score: 0.695
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.